Biomarkers and Novel PET Imaging to Detect Neuroendocrine Prostate Cancer

H&O  What is neuroendocrine prostate cancer (NEPC), and how common is it?  RA  NEPC is an aggressive histologic subtype of prostate cancer. The de novo form […]

Overcoming Immune Evasion in Advanced Prostate Cancer

H&O  Why do some patients with prostate cancer respond to immune checkpoint inhibitors (ICIs), whereas others do not? AA  Several clinical trials with ICIs, either alone […]

More Highlights in Prostate Cancer From the 2023 American Society of Clinical Oncology Annual Meeting

June 2-6, 2023  •  Chicago, Illinois and Virtual Last month, Clinical Advances in Hematology & Oncology highlighted the PEACE-1 trial, the TALAPRO-2 study, and research on […]

Predictive Biomarkers in Advanced Prostate Cancer

H&O  What is the difference between a prognostic biomarker and a predictive biomarker? AA  Prognostic biomarkers estimate the natural history of a disease, or in other […]

The Use of AI to Identify Predictive, Pathology-Based Biomarkers in Men With Prostate Cancer

H&O  How is artificial intelligence (AI) defined in the context of cancer biomarkers, including predictive biomarkers?  DS  AI is a very general term, of course, that […]

When to Use Somatic Tumor Testing in Prostate Cancer

H&O  Which patients with prostate cancer are eligible for somatic tumor testing?  TF  To begin with, we should be clear about some definitions. Somatic tumor testing […]

Update on Metastatic Hormone-Sensitive Prostate Cancer

H&O  How often do men present with de novo metastatic prostate cancer?  KC  In places where we do a lot of screening, such as the United […]

Special Concerns for Survivors of Prostate Cancer

Clinical Advances in Hematology & Oncology Volume 14, Issue 9, September 2016 Andrew C. Peterson, MD Professor of Urologic Surgery Duke University School of Medicine Durham, […]

The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer

Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Oliver Sartor, MD LaBorde Professor for Cancer Research Medical Director Tulane Cancer Center Departments of […]